par Paridaens, R.
;Biganzoli, Laura
;Bruning, Peter;Klijn, J G;Gamucci, T;Houston, S;Coleman, R;Schachter, J;Van Vreckem, Ann;Sylvester, R.;Awada, Ahmad
;Wildiers, J;Piccart-Gebhart, Martine 
Référence Journal of clinical oncology, 18, 4, page (724-733)
Publication Publié, 2000-02




Référence Journal of clinical oncology, 18, 4, page (724-733)
Publication Publié, 2000-02
Article révisé par les pairs
Titre: |
|
Auteur: | Paridaens, R.; Biganzoli, Laura; Bruning, Peter; Klijn, J G; Gamucci, T; Houston, S; Coleman, R; Schachter, J; Van Vreckem, Ann; Sylvester, R.; Awada, Ahmad; Wildiers, J; Piccart-Gebhart, Martine |
Informations sur la publication: | Journal of clinical oncology, 18, 4, page (724-733) |
Statut de publication: | Publié, 2000-02 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adenocarcinoma -- drug therapy |
Adenocarcinoma -- secondary | |
Adult | |
Aged | |
Antibiotics, Antineoplastic -- administration & dosage | |
Antibiotics, Antineoplastic -- adverse effects | |
Antibiotics, Antineoplastic -- therapeutic use | |
Antineoplastic Agents, Phytogenic -- administration & dosage | |
Antineoplastic Agents, Phytogenic -- adverse effects | |
Antineoplastic Agents, Phytogenic -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Chi-Square Distribution | |
Cross-Over Studies | |
Disease Progression | |
Doxorubicin -- administration & dosage | |
Doxorubicin -- adverse effects | |
Doxorubicin -- therapeutic use | |
Drug Resistance, Neoplasm | |
Female | |
Follow-Up Studies | |
Humans | |
Infusions, Intravenous | |
Injections, Intravenous | |
Logistic Models | |
Middle Aged | |
Paclitaxel -- administration & dosage | |
Paclitaxel -- adverse effects | |
Paclitaxel -- therapeutic use | |
Proportional Hazards Models | |
Remission Induction | |
Survival Rate | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Comparative Study | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/jco.2000.18.4.724 | |
info:scp/0033956932 | |
info:pmid/10673513 |